Michael Mason, VP, Finance and Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 4,791 shares at $130.39 ($632K) on 2015-06-01, disclosed to the SEC on 2015-06-03.
Scheduled sale ($632k) by VP, Finance and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.39 | 760 | $99K | 15.7% |
| 2 | $131.56 | 1,767 | $232K | 36.8% |
| 3 | $132.49 | 2,064 | $273K | 43.3% |
| 4 | $133.12 | 200 | $27K | 4.2% |
| Total | $131.84 avg | 4,791 | $632K | 100% |
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |